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background:  Diabetes (DM) is a risk factor for recurrent ischemic events in patients with coronary artery disease. However, the difference 
in vascular response to statin therapy between patients with and without DM is largely unknown.
Methods:  From a randomized trial (NCT01023607), we identified 97 lipid-rich plaques from 69 patients who were randomized to receive 
atorvastatin 60mg, rosuvastatin 10mg or atorvastatin 20mg. Serial OCT and IVUS imaging were performed at baseline, 6-month, and 
12-month. We compared the fibrous cap thickness (FCT) and mean lipid arc by OCT, and the percent atheroma volume (PAV) by IVUS 
between patients with and without DM.
Results:  The baseline characteristics were comparable between patients with DM (n=34) and without DM (n=35) other than the 
prevalence of smoker (32.4% vs. 62.9%, P=0.01). The baseline FCT (61.4 ± 16.2 vs. 60.8 ± 20.7, µm, P=0.87), mean lipid arc (177.2 ± 
47.0º vs. 172.5 ± 56.1º, P=0.66) and PAV (56.6 ± 9.46 vs. 53.9 ± 9.17, P=0.16) were also similar between the two groups. At 12-month, 
PAV was significantly greater in DM than in non-DM (57.1 ± 8.63 vs. 52.6 ± 9.29, P=0.02), while the FCT and lipid arc remain similar 
between the two groups (Figure).
conclusion:  In DM patients with coronary artery disease, PAV became greater compared to non-DM patients despite of the 12-month 
statin therapy. This result may partly explain the worse outcome in DM patients despite statin therapy.
 
